BRIXELLE

Class [005]
Pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for use in the treatment of musculoskeletal diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceuticals for the treatment of erectile dysfunction; human pharmaceutical vaccines; anti-inflammatory preparations; intestinal disorder medicine for the treatment of irritable bowel syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; cardiovascular pharmaceutical preparations; ophthalmic preparations; biological preparations made from human blood cells for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; diagnostic preparations for medical laboratory use; reagents for use in medical testing for COVID-19 and other coronavirus diseases; medical reagents for testing genetic identity; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human vaccine preparations; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; preparations for the treatment of asthma; pharmaceutical preparations for the treatment of dental and oral diseases; dermatological pharmaceutical preparations for the treatment of dermatitis, skin pigmentation diseases and psoriasis; medicated skin care preparations for treating, reducing, and preventing lines, pores, and loss of skin firmness; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; antibiotics; anti-cancer preparations; tumor suppressing agents; pharmaceutical products for treating respiratory diseases.